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ABSTRACT
Objective: To study the association between sleep duration and stroke incidence in a British pop-
ulation and to synthesize our findings with published results through a meta-analysis.
Methods: The prospective study included 9,692 stroke-free participants aged 42–81 years from the
EuropeanProspective Investigation intoCancer–Norfolk cohort. Participants reported sleep duration in
1998–2000 and 2002–2004, and all stroke cases were recorded until March 31, 2009. For the
meta-analysis, we searched OvidMedline, EMBASE, and the Cochrane Library for prospective studies
published until May 2014, and pooled effect estimates using a weighted random-effect model.
Results: After 9.5 years of follow-up, 346 cases of stroke occurred. Long sleep was significantly
associated with an increased risk of stroke (hazard ratio [HR]51.46 [95%confidence interval (CI)
1.08, 1.98]) after adjustment for all covariates. The association remained robust among those
without preexisting diseases and those who reported sleeping well. The association for short
sleep was smaller (and not statistically significant) (HR 5 1.18 [95% CI 0.91, 1.53]). There
was a higher stroke risk among those who reported persistently long sleep or a substantial
increase in sleep duration over time, compared to those reporting persistently average sleep.
These were compatible with the pooled HRs from an updated meta-analysis, which were 1.15
(1.07, 1.24) and 1.45 (1.30, 1.62) for short and long sleep duration, respectively.
Conclusions: This prospective study and meta-analysis identified prolonged sleep as a potentially
useful marker of increased future stroke risk in an apparently healthy aging population. Neurology®
2015;84:1–8
GLOSSARY
BMI 5 body mass index; CI 5 confidence interval; CVD 5 cardiovascular disease; DBP 5 diastolic blood pressure; HR 5
hazard ratio; ICD-9 5 International Classification of Diseases–9; ICD-10 5 International Classification of Diseases–10;
MDD 5 major depressive disorder; MI 5 myocardial infarction; SBP 5 systolic blood pressure.
Sleep is increasingly suggested as a predictor of cardiovascular events,1,2 and stroke is an outcome
of particular interest. One meta-analysis in 20092 included 4 studies on sleep and stroke3–6 and
concluded a U-shaped relationship, with both short and long sleep being associated with an
increased stroke risk.
Increasing numbers of prospective studies have examined this association in the past 5 years.7–10
These studies have examined various types of populations with different follow-up durations, with
inconsistent results. While several earlier studies observed strong effects for long sleep and sug-
gested a J-shaped relationship,3,4,11 the most recent study found a U-shaped association between
sleep duration and risk of stroke mortality in a large sample of Chinese adults.8 It is unclear
whether this association is applicable to nonfatal stroke, and if this could be modified by sleep
quality. Meanwhile, evidence is lacking from the British population, and no study has exam-
ined change in sleep duration over time and subsequent stroke risk. Understanding this
relationship is potentially important for the early detection of stroke, especially in older
populations. Therefore, we aimed to update the meta-analysis, and to study the effects of
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sleep duration and change in sleep duration
on stroke incidence in a middle- to older-aged
British population. We evaluated both fatal and
nonfatal stroke and explored whether the asso-
ciations varied by follow-up length, stroke
subtypes, and sleep quality.
METHODS Study population. The study population was
drawn from the European Prospective Investigation of Cancer–
Norfolk cohort study. Details about study design have been
described previously.12 Briefly, we recruited 25,639 men and
women aged 40–79 years using general practice age–sex registers
from Norfolk, UK, during 1993–1997, and followed them up for
health outcomes. As part of the follow-up, participants were sent
questionnaires for completion.
Standard protocol approvals, registrations, and patient
consents. The Norwich District Ethics Committee approved the
study and all participants gave signed informed consent.
Measures of sleep. During 1998–2000, 16,643 people
answered the following question: “On average, how many hours
do you sleep in a 24-hour period?” with 6 response options: ,4,
4–6, 6–8, 8–10, 10–12, and .12. This question was repeated
during 2002–2004.
In addition, participants were asked “Do you generally sleep
well?” with response alternatives “yes” and “no.”
Ascertainment of stroke cases. At baseline, we excluded partic-
ipants with self-reported history of doctor-diagnosed stroke or those
whose date of stroke onset was before the date of sleep report.
All stroke cases to March 31, 2009, were taken as the first
occurrence of either hospital admission or death due to stroke.
We defined nonfatal stroke as hospital admission due to stroke
that did not lead to death (in the same month), and recorded
information through linkage with the National Health Services
district database. We obtained information on fatal stroke
through linkage with the UK Office of National Statistics. Stroke
cases were classified according to ICD-9 as codes 430-438
(hemorrhagic stroke 430-432; cerebral infarction 433-435; stroke
unspecified or other 436-438) or according to ICD-10 as codes
I60-I69 (hemorrhagic stroke I60-I62; ischemic stroke I63, I65, and
I66; stroke unspecified or other I64 and I67-I69).
Covariates. We chose all covariates a priori based on literature
and relevance to sleep and stroke. Those reported from question-
naires included age, sex, social class (professionals, managerial,
and technical occupations, skilled workers subdivided into non-
manual and manual, partly skilled workers, and unskilled manual
workers), education (no qualifications, educated to age 16, edu-
cated to age 18, and educated to degree level), marital status (single,
married, widowed, separated, and divorced), smoking (current, for-
mer, and nonsmokers), alcohol intake (units of alcohol per week),
family history of stroke, hypnotic drug use, physical activity (inac-
tive, moderately inactive, moderately active, active), major depres-
sive disorder (MDD) in the previous year, preexisting myocardial
infarction (MI) and diabetes, and use of antihypertension drugs.
Other objectively measured confounders included body
mass index (BMI; weight in kilograms divided by height in
meters squared); systolic blood pressure (SBP) and diastolic
blood pressure (DBP), both in mm Hg, based on the mean
of 2 readings taken by trained nurses; and serum cholesterol
level estimated from nonfasting blood samples taken by vene-
puncture, using colorimetry (RA 1000, Bayer Diagnostics,
Basingstoke, UK).
Statistical analysis.We defined the response categories for sleep
duration as short (,6 hours), average (6–8 hours), and long (.8
hours) due to the low frequency of extreme sleep durations. First,
we compared baseline characteristics of the participants by sleep
duration using x2 test. Cox proportional hazard models were fit-
ted to obtain hazard ratios (HR), with average sleep being the
reference group. We constructed models with progressive adjust-
ment of the covariates to show the associations explained by the
covariates and performed the analysis in those with complete data
on all covariates (A) adjusted for age and sex; (B) further adjusted
for social class, education, marital status, smoking, alcohol intake,
hypnotic drug use, and family history of stroke; and (C) further
adjusted for BMI, physical activity, MDD, SBP, DBP, preexist-
ing MI and diabetes, serum cholesterol level, and hypertension
drug use. We repeated these analyses for fatal and nonfatal stroke,
and presented the results by sex.
Change in sleep duration from 1998–2000 to 2002–2004
was modeled through combinations of the 3 duration categories
during each time period, giving 9 subcategories. The association
between change in sleep duration and overall incidence risk of
stroke was examined using model C, with “constantly average”
being the reference group, and was conducted in the whole sam-
ple to retain power. Finally, we performed subgroup analysis
according to follow-up length, sleep quality, preexisting diseases,
stroke subtypes, and other potential effect modifiers using model B.
Analyses were implemented in STATA, version 12.0 (StataCorp LP,
College Station, TX).
Meta-analysis of prospective studies on the association
between sleep duration and stroke incidence. We con-
ducted an updated systematic review and meta-analysis using
methods described in detail elsewhere.2 We searched
longitudinal population studies (published up to May 2014)
reporting the association between sleep duration and fatal and
nonfatal stroke (appendix e-1 on the Neurology® Web site at
Neurology.org), with the following restrictions: original article,
prospective cohort design, and adult population. Studies with no
complete information presented for stroke events were contacted,
and were excluded if no additional estimates could be obtained.
Data were extracted independently by 2 investigators (Y.L. and
F.P.C.). Short sleep was defined as#5–6 hours and long sleep as
$8–9 hours. When multiple multivariate models were fitted, we
extracted the estimates that were least likely to have been
confounded (models with most covariates). Effect estimates
were pooled using a weighted random-effect model. We tested
for heterogeneity among studies,13 publication bias by funnel plot
asymmetry and Egger test,14 and carried out sensitivity analyses.2
All analyses were performed using Review Manager software (v5)
(Copenhagen, 2011). We evaluated the quality of studies,15 and
the study adheres to the PRISMA Statement guidelines for
nonrandomized studies.16
RESULTS After excluding participants with self-
reported preexisting stroke (n 5 438) and those
whose date of stroke onset was before the date of
sleep report (n 5 623), the final study sample
included 9,692 participants who had complete data
on all covariates.
At baseline, the participants were aged from 42 to
81 years (mean 61.6). A total of 6,684 (69%) of the
participants reported sleeping for 6–8 hours per day,
while 10% reported sleeping for .8 hours. Table 1
shows baseline characteristics by sleep duration.
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Participants with ,6 hours or .8 hours of sleep
were older, more likely to be women, less active,
to have MDD, and to be taking antihypertensive
drugs. No significant association was found between
sleep duration and BMI, SBP, or preexisting diabe-
tes or MI.
A total of 346 participants had at least one incident
fatal or nonfatal stroke during a mean of 9.5 years of
follow-up. There were 67 fatal stroke and 300 hospital
admissions, with 21 participants being admitted to
hospital before subsequent death. Univariate analysis
suggested that those who reported ,6 hours and .8
hours of sleep had 32% and 71% increased risk of
having a stroke incident, respectively. Table 2 summa-
rizes the adjusted HRs associated with short and long
sleep. After adjustment for age and sex, short and long
sleep were associated with 19% and 45% increase in
the risk of stroke, respec-
tively. These estimates were
hardly changed after further
adjustment for potential
confounders. The associa-
tion was stronger for
women, although a formal
test for sex difference was
not statistically significant
(p 5 0.24). When we
examined stroke outcomes
separately, the association
was more pronounced for
fatal stroke (table e-1).
Table 3 shows the asso-
ciation between change in
sleep duration and stroke
risk. The risk doubled for
those reporting persis-
tently long sleep, com-
pared to those with
persistently average sleep
duration. This risk was
even greater for those
whose reported sleep
increased from short to
long over the 4 years (HR
5 3.75 [95% confidence
interval (CI), 1.17,
12.05]). Finally, subgroup
analysis (table e-2) sug-
gested that the association
remained among those
without preexisting dis-
eases, did not attenuate
by increasing length of
follow-up, and was more
pronounced for those
who reported sleeping well
(p for interaction 5 0.01). The association for short
sleep was strong among younger people (HR5 1.87
[0.97, 3.60]) and the association for long sleep was
only significant among those aged 63 years and older
(HR 5 1.50 [1.09, 2.05]) (p for interaction 5
0.98). The association was stronger between short
sleep and ischemic stroke and between long sleep
and hemorrhagic stroke.
Systematic review and meta-analysis. Eleven
studies3–8,10,11,17–19 identified from the search along
with the current study were included (table e-3) in the
meta-analysis. Six studies reported outcomes separately
for men and women, and were entered as separate
cohorts. The final analysis included 559,252
participants from 7 countries. All studies measured
sleep duration by questionnaire, and 6 only reported
Table 1 Baseline characteristics by sleep duration in the European Prospective Investigation of
Cancer–Norfolk study, 1998–2000
Total,
n (%) <6 h (n 5 2,022), n (%) 6–8 h (n 5 6,684), n (%) >8 h (n 5 986), n (%)
Age, y
42–52 1,819 333 (16.5)a 1,324 (19.8) 162 (16.4)
52–62 3,384 702 (34.7) 2,374 (35.5) 308 (31.2)
62–72 3,140 634 (31.4) 2,158 (32.3) 348 (35.3)
72–82 1,349 353 (17.5) 828 (12.4) 168 (17.0)
Male sex 4,444 807 (39.9)a 3,204 (47.9) 433 (43.9)
Nonmanual social class 6,359 1,267 (62.7)b 4,448 (66.5) 644 (65.3)
A-level and higher education 5,733 1,086 (53.7)a 4,060 (60.7) 587 (59.5)
Married 8,012 1,559 (77.1)a 5,617 (84.0) 836 (84.8)
Current or former smoker 4,983 1,047 (51.8) 3,423 (51.2) 513 (52.0)
Alcohol intake ‡8 units/wkc 4,655 924 (45.7) 3,248 (48.6) 483 (49.0)
Hypnotics use 145 80 (4.0)a 59 (0.9) 6 (0.6)
Family history of stroke 7,291 501 (24.8) 1,655 (24.8) 245 (24.8)
BMI >26.5c 4,757 1,028 (50.8) 3,228 (48.3) 501 (50.8)
Physical activity
Inactive 2,383 570 (28.2)a 1,548 (23.2) 265 (26.9)
Moderately inactive 2,912 578 (28.6) 2,048 (30.6) 286 (29.0)
Moderately active 2,429 484 (23.9) 1,715 (25.7) 230 (23.3)
Active 1,968 390 (19.3) 1,373 (20.5) 205 (20.8)
Major depressive disorder 441 138 (6.8)a 248 (3.7) 55 (5.6)
Hypertension drug use 2,039 493 (24.4)a 1,323 (19.8) 223 (22.6)
Systolic blood pressure ‡137 mm Hgc 4,842 1,019 (50.4) 3,301 (49.4) 522 (52.9)
Cholesterol level ‡5.9 mmol/Lc 4,650 974 (48.2) 3,192 (47.8) 484 (49.1)
Self-reported diabetes 254 49 (2.4) 177 (2.6) 28 (2.8)
Self-reported heart attack 293 70 (3.5) 185 (2.8) 38 (3.9)
Abbreviation: BMI 5 body mass index.
ap , 0.005.
bp , 0.01.
cCutoff by median.
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fatal stroke events. Over a follow-up of 7.5–35 years, a
total of 11,695 stroke events were reported. The figure
shows the pooled effects for short (A) and long (B)
sleep, respectively. The addition of the current study
did not alter the overall estimates of effect for both
short and long sleep. For short sleep, the pooled
relative risk (RR) was 1.15 (95% CI, 1.07, 1.24;
p 5 0.0002), with no evidence of heterogeneity. For
long sleep, the pooled RR was 1.45 (1.30, 1.62), with
significant between-study heterogeneity (I2 5 54%;
p 5 0.003). After repeating the meta-analysis
excluding the study by Westerlund et al.,7 the
heterogeneity disappeared (RR, 1.53; 95% CI, 1.42,
1.65; p , 0.00001; I2 5 0%).
DISCUSSION In this middle-to older-aged British
population, we observed a
J-shaped relationship
between daily sleep
duration and 9.5-year
stroke risk. Those with
short sleep had an 18%
increased stroke risk (not
statistically significant),
while long sleep was
associated with a 46%
increase in stroke risk after
adjustment for
conventional cardiovascular
disease (CVD) risk factors
and comorbidities. Those
who reported persistently
long sleep and those who
reported substantially
increased sleep had at least
double the stroke risk
compared to those with
persistently average sleep
Table 2 Hazard ratios (95% confidence intervals) of sleep duration for stroke incidence, 1998–2009
No. of patients
<6 h
6–8 h, referent
>8 h
Overall paHR 95% CI HR 95% CI
All (n 5 9,692) 346
Model 1b 1.19 (0.92, 1.53) 1.00 1.45 (1.07, 1.97) 0.05
Model 2c 1.16 (0.90, 1.51) 1.00 1.45 (1.07, 1.97) 0.05
Model 3d 1.18 (0.91, 1.53) 1.00 1.46 (1.08, 1.98) 0.05
Men (n 5 4,444) 198
Model 1b 1.14 (0.80, 1.63) 1.00 1.24 (0.82, 1.87) 0.52
Model 2c 1.07 (0.74, 1.54) 1.00 1.24 (0.82, 1.87) 0.59
Model 3d 1.08 (0.75, 1.57) 1.00 1.21 (0.80, 1.82) 0.67
Women (n 5 5,248) 148
Model 1b 1.24 (0.86, 1.79) 1.00 1.83 (1.16, 2.89) 0.04
Model 2c 1.26 (0.86, 1.84) 1.00 1.78 (1.12, 2.82) 0.05
Model 3d 1.25 (0.86, 1.83) 1.00 1.80 (1.13, 2.85) 0.05
Abbreviations: CI 5 confidence interval; HR 5 hazard ratio.
a Tested by likelihood ratio test.
bAdjusted for age and sex.
c Adjusted for age, sex, social class, education, marital status, smoking, alcohol intake, hypnotic drug use, and family history of stroke.
dAdjusted for age, sex, social class, education, marital status, smoking, alcohol intake, hypnotic drug use, family history of stroke, body mass index, physical
activity, depression, hypnotic drug use, systolic blood pressure, diastolic blood pressure, preexisting diabetes and myocardial infarction, cholesterol level,
and hypertension drug use.
Table 3 Change in sleep duration over 2 measurements and stroke incidence, 1998–2009
Sleep durationa
No. of patients
Stroke incidence risk
1998–2000 2002–2004 HR 95% CI
Average Average 6,646 1.00 Referent
Short Average 905 1.30 (0.74, 2.18)
Long Average 608 1.33 (0.74, 2.38)
Short Short 1,759 1.11 (0.71, 1.73)
Average Short 1,161 1.12 (0.66, 1.88)
Long Short 45 1.36 (0.18, 9.91)
Average Long 825 1.53 (0.96, 2.44)
Long Long 648 2.01b (1.26, 3.23)
Short Long 52 3.75c (1.17, 12.05)
Abbreviations: CI 5 confidence interval; HR 5 hazard ratio.
a Short: ,6 hours; average: 6–8 hours; long: .8 hours.
bp , 0.01.
cp , 0.05 adjusted for age, sex, social class, education, marital status, smoking, alcohol intake, hypnotic drug use, family
history of stroke, body mass index, physical activity, depression, hypnotic drug use, systolic blood pressure, diastolic blood
pressure, preexisting diabetes and myocardial infarction, cholesterol level, and hypertension drug use.
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duration. Our findings are compatible with an updated
meta-analysis, which suggested a pooled RR of 1.15
(1.07, 1.24) and 1.45 (1.30, 1.62) for short and long
sleep, respectively.
This study benefits from the prospective design,
particularly the ability to examine the longitudinal
change in sleep duration. Both fatal and nonfatal
stroke events were examined, and sex-specific esti-
mates were provided. The study also explored
whether the association differed by comorbidities,
general sleep quality, and stroke subtypes, which
helps to provide more insights into potential mecha-
nisms. The meta-analysis including over 8,000 stroke
cases, substantially greater than that included in pre-
vious work,2 provides external validity to our find-
ings. There are several limitations. First, this study
included 9,692 stroke-free participants who were
younger and had higher social class and educational
level compared to the baseline population, but the
external validity is supported by the agreement with
the meta-analysis. As with previous studies, sleep
duration was reported via a single question, which
might reflect perception of sleep rather than biologi-
cal sleep. It should be noted that one’s perception of
sleep could be influenced by poor cognitive function
or physical health.20,21 This is potentially problematic
for older adults and for those with preclinical minor
stroke, whose perception of sleep might be impaired
due to cognitive factors. However, examination of
change in sleep duration was in line with results on
a single measure of sleep at baseline. From a practical
standpoint, evaluation of sleep durations using self-
reported data are more feasible in primary care set-
tings. Although a range of potential confounders were
included in the analysis, we could not rule out the
possibility of residual confounding. For example, the
effects of unmeasured health or sleep problems (e.g.,
obstructive sleep apnea or snoring) cannot be over-
looked, particularly on the association for long sleep.
We evaluated general sleep quality by asking if one
generally sleeps well. This is a relatively crude mea-
sure, and we were unable to differentiate between
short sleep due to poor sleep quality or time con-
straints and natural short sleepers. However, our
observation on the interaction between perception
of sleep duration and general sleep quality provides
interesting insights to the problem and stresses the
need for further studies. Finally, failure to reach sta-
tistical significance in the short sleep group may
reflect low statistical power due to the small number
of events. In order to retain power, we have defined
short sleepers as those who reported sleeping less than
6 hours, and might have failed to detect the associa-
tion for extremely short sleepers as reported by pre-
vious studies.22,23 While the association for short sleep
could have been underestimated, the point estimate
was compatible with that of the meta-analysis.
In accordance with previous studies,3,4,6,8,11 we
found a robust association between long sleep and
increased stroke risk. The Women’s Health Initiative
study has shown similar results on the risk of ischemic
stroke among postmenopausal women.4 We extended
the analysis to all stroke events in both sexes, and
suggested a stronger association among women. The
Singapore Chinese Health Study8 found both short
and long sleep to be associated with mortality from
ischemic or unspecified stroke, while our study sug-
gested an association between short sleep and risk of
ischemic stroke, and between long sleep and hemor-
rhagic stroke. It is unclear why different sleep lengths
might be associated with different stroke subtypes.
Notably, the numbers in each subtypes of stroke were
relatively small, and larger studies are required to rep-
licate our findings and help to inform mechanisms.
A few studies on middle-aged participants have re-
ported either no association between sleep duration
and stroke risk7,17 or association only for short sleep.10
A recent study suggested an increased risk of stroke
associated with insomnia, particularly in young
adults.9 Consistent with these studies, we found the
association for short sleep stronger among younger
participants, but for long sleep more pronounced
among the older ones, although test for interaction
was not statistically significant. Short and long sleep
might have different implications in different age
groups, and the interaction by age needs to be tested
by larger studies in the future. Although it is possible
for older people to sleep more due to less work and
social demands, we have previously suggested
decreased self-reported sleep duration for older par-
ticipants despite long time spent in bed in this
cohort.24 Therefore, it is worth noting excessive sleep
as an early sign of increased stroke risk, particularly
among older people. This study suggests that those
who reported persistently long sleep or substantially
increased sleep had a much higher stroke risk. This
again points to the importance of detecting prolonged
sleep among the aging population. While there are no
other studies with which to directly compare our
findings, stability of sleep as a trait is important25
and future studies are needed to explore this matter.
The underlying mechanisms are not fully under-
stood. Sleep deprivation has been linked to disrupted
metabolism and increased cortisol secretion, sympa-
thetic nervous activity, and low-grade inflammation,
which might lead to elevated blood pressure, inter-
rupted blood flow, and increased stroke risk.26–28
The present prospective study and the updated
meta-analysis, however, have both suggested a stron-
ger association for long sleep duration, independent
of conventional CVD risk factors. This raises the
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question of whether long sleep could be a cause, con-
sequence, or early marker of ill health.29 One impor-
tant biological pathway is through inflammation, as
long sleep has been associated with an increased level
of inflammatory biomarkers.30,31 Interestingly, a
number of studies have associated long sleep with
cardiovascular conditions including carotid artery
atherosclerosis, atrial fibrillation, white matter
hyperintensity volume, and left ventricular mass,
which might have predisposed one to the risk of
stroke.32–37 These further supported the assumption
of long sleep being a risk factor for stroke. Meanwhile,
some studies suggested an association for long sleep
and stroke only among those with limited physical
function18 or with a history of hypertension.8 The First
National Health and Nutrition Examination Survey
Figure Forest plot of the risk of stroke associated with sleep duration
Association between short (A) and long (B) sleep duration and risk of stroke. Results are presented as pooled relative risk and 95% confidence interval (CI).
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(NHANES I) concluded that long sleep might repre-
sent underlying sleep-specific disease.3 Notably, our
study remained robust among those without comor-
bidities or who reported sleeping well, and did not
attenuate with increasing length of follow-up, which
makes reverse causality an unlikely explanation. Long
sleep might be an early sign of system dysregulation
and future stroke risk in an apparently healthy, aging
population. Further targeted research is needed to
examine the additional contribution of habitual sleep
duration to existing risk prediction models of stroke.
The mechanisms for the health risk associated with
long sleep duration should be investigated using exper-
imental designs.38
This prospective study and meta-analysis sug-
gested a significant increase in stroke risk among long
sleepers and a modest increase among short sleepers.
Persistently long sleep or marked increase in sleep
duration were associated with subsequent risk of
stroke. The underlying mechanism needs further
investigation. Prolonged sleep might be a useful
marker of increased stroke risk in older people, and
should be tested further for its utility in clinical
practice.
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